Johnson & Johnson (JNJ): Director received 134.24 units
Daniel E Pinto, Director at Johnson & Johnson, reported a grant / award of 134.24 units.
- 134.24
- Derivative units · @ $232.79
- Traded
- Jun 9, 2026
- Filed
- Jun 11, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 16, 2025Federal contractDepartment of Veterans Affairs awarded Johnson & Johnson: $0 obligated to date
- Feb 23, 2026Federal contract · $371K obligatedDepartment of Defense awarded Johnson & Johnson: $371K obligated to date
- Feb 26, 2026Federal contract · $272K obligatedDepartment of Defense awarded Johnson & Johnson: $272K obligated to date
- Mar 4, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
- Mar 16, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
- Mar 19, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Mar 26, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Mar 27, 2026CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
- Mar 30, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Apr 10, 2026Federal contract · $198K obligatedDepartment of Defense awarded Johnson & Johnson: $198K obligated to date
- Apr 14, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 28, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
- Jun 2, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Jun 9, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
What came next
- Jun 11, 2026Insider · First sale since 2023Officer sold ~$2.41M of JNJ shares in the open market
- Jun 29, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Jul 7, 2026Federal contract · $168K obligatedDepartment of Defense awarded Johnson & Johnson: $168K obligated to date
- Jul 15, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 20, 2026InsiderOfficer sold ~$5.79M of JNJ shares in the open market
- Jul 23, 2026Federal contract · $182K obligatedDepartment of Defense awarded Johnson & Johnson: $182K obligated to date
- Jul 25, 2026FDAFDA device clearance: MONARCH Platform (MON-000008)
- Jul 27, 2026FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
- Jul 30, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
- Jul 30, 2026CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Jul 31, 2026FDARecall: HEALON EndoCoat PRO, REF: 10300012 (US/CAN) HEALON DUET PRO II, REF: 10300016 (US/CAN) HEALON EndoCoat PRO, REF: 10301012 (EU); HEALON DUET PRO II, REF: 103010…
- Jul 31, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
- Aug 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.”
- Aug 5, 2026Insider · 1 personInsiders: 2 sales (~$12.5M)
- Aug 6, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
- Aug 12, 2026FDARecall: Automated Impella Controller (AIC) with the below product descriptions and corresponding Product Codes. 1. Impella Controller, Packaged, CA; Product Code: 0042…
- Aug 12, 2026FDARecall: Impella Optical Controller, Automated Impella Controller, Impella Connect Package with the below product descriptions and corresponding Product Codes. 1. Optic…
- Aug 12, 2026FDARecall: Impella Optical Controller with the below product descriptions and corresponding Product Codes. 1. Impella Optical Controller, Packaged, AU; Product Code: 0042…
- Aug 13, 2026Insider · 1 personInsiders: 2 sales (~$32.2M)
- Aug 17, 2026Insider · Named in an 8-K 13 days earlierOfficer sold ~$3.95M of JNJ shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Johnson & Johnson
For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.
How this filing works
Explore the data
Common questions
Which Johnson & Johnson (JNJ) insider traded, and how much?
Daniel E Pinto, Director at Johnson & Johnson, reported a grant / award of 134.24 units. At $232.79.
When did it happen, and when was it made public?
Traded: Jun 9, 2026. Filed: Jun 11, 2026. That is 2 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Johnson & Johnson recently?
For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the JNJ page.
Does this mean JNJ stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Johnson & Johnson
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 13, 2026
- USAspending.gov award recordNov 13, 2026
- SEC Form 144Nov 12, 2026
- House Clerk periodic transaction reportOct 30, 2026
- House Clerk periodic transaction reportOct 5, 2026
Everything OQRO holds on this company is on its JNJ page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
